2013
DOI: 10.1002/anie.201302045
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of Neuritogenic Compound Classes Inspired by Natural Products

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
33
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 74 publications
(34 citation statements)
references
References 67 publications
0
33
0
1
Order By: Relevance
“…By truncating natural product lead structures, several groups have identifi ed functionally optimized and structurally simplifi ed compounds. [ 22,26,27 ] However, in all these reports, experiments were carried out in solution, and, to the best of our knowledge, no study described the use of neuritogenic small molecules We chose to screen a range of different fi nal concentrations from 10 × 10 −9 to 10 × 10 −3 M , using the same experimental setup as described above. As can be seen in Figure 3 , surfaces generated from coating solution concentrations ranging from 1 × 10 −3 to 100 × 10 −9 M signifi cantly induced neurite outgrowth.…”
Section: Doi: 101002/adhm201300671mentioning
confidence: 99%
“…By truncating natural product lead structures, several groups have identifi ed functionally optimized and structurally simplifi ed compounds. [ 22,26,27 ] However, in all these reports, experiments were carried out in solution, and, to the best of our knowledge, no study described the use of neuritogenic small molecules We chose to screen a range of different fi nal concentrations from 10 × 10 −9 to 10 × 10 −3 M , using the same experimental setup as described above. As can be seen in Figure 3 , surfaces generated from coating solution concentrations ranging from 1 × 10 −3 to 100 × 10 −9 M signifi cantly induced neurite outgrowth.…”
Section: Doi: 101002/adhm201300671mentioning
confidence: 99%
“…1 While proteins that serve in this regard (neurotrophins) have been investigated as potential therapeutic agents, they suffer from a variety of suboptimal characteristics that negatively impact their potential utility in the clinic ( i.e. low serum stability, poor oral bioavailability, and inefficient penetration into the central nervous system).…”
mentioning
confidence: 99%
“…low serum stability, poor oral bioavailability, and inefficient penetration into the central nervous system). 1a, 2 As such, there has been growing interest in identifying small molecule neurotrophic agents that have a more favorable pharmacokinetic profile. 3 While early investigations of the seeds of the Japanese star anise ( Illicium anisatum, L. ) delivered anisatin, 4 a neurotoxic noncompetitive GABA antagonist, 5 more recent studies of Illicium terrestrial plants (evergreen shrubs/trees) have delivered a collection of complex carbocyclic natural products that have been shown to possess potent neurotrophic properties (Figure 1).…”
mentioning
confidence: 99%
“…Recently,w eh ad successfully explored amino-acid-derived chiral alkyldiphenylphosphines in asymmetric annulation reactions. [15] Amongt he two aminophosphines (3d-e)t ested, only the l-threonine derived one (3e)a fforded am oderate yield and improved enantioselectivity for the major syn-isomer of adduct 4a (entries 4-5). A chiral diamine-based phosphine ligand 3f also failed to provide the desired result (entry 6).…”
mentioning
confidence: 99%